David Bonita
Directeur/Membre du Conseil chez ACUTUS MEDICAL, INC.
Fortune : 447 $ au 30/06/2024
Profil
David P.
Bonita is currently an Independent Director at Acutus Medical, Inc., Prelude Therapeutics, Inc., Repare Therapeutics, Inc., Third Harmonic Bio, Inc., Treeline Biosciences, Inc., Ikena Oncology, Inc., and Secretary at Auraeda, Inc. He is also a General Partner at OrbiMed Advisors Private Equity and a Member at Orbimed Private Investments VII LP.
In the past, Dr. Bonita served as Chairman at Clementia Pharmaceuticals, Inc., Independent Director at Ambit Biosciences Corp., ViewRay Technologies, Inc., and Loxo Oncology, Inc. He was also a Director at Edwards Lifesciences CardiaQ LLC, SI-BONE, Inc., ViewRay, Inc., Tricida, Inc., Enobia Pharma, Inc., Imaxio SA, Keystone Heart Ltd., Sublimity Therapeutics Ltd., Cryterion Medical, Inc., and a Finance Analyst at Morgan Stanley and UBS Securities LLC.
Dr. Bonita obtained an MBA and a doctorate from The Trustees of Columbia University in The City of New York.
He also holds an undergraduate degree from Harvard University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ACUTUS MEDICAL, INC.
0,04% | 31/12/2023 | 12 422 ( 0,04% ) | 447 $ | 30/06/2024 |
REPARE THERAPEUTICS INC.
-.--% | 17/06/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
IKENA ONCOLOGY, INC.
-.--% | 07/06/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de David Bonita
| Sociétés | Poste | Début |
|---|---|---|
| ACUTUS MEDICAL, INC. | Directeur/Membre du Conseil | 01/03/2016 |
| PRELUDE THERAPEUTICS INCORPORATED | Directeur/Membre du Conseil | 01/07/2016 |
| REPARE THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/09/2019 |
| IKENA ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/01/2016 |
| THIRD HARMONIC BIO, INC. | Directeur/Membre du Conseil | 01/07/2020 |
| Auraeda, Inc. | Secrétaire Général | 01/10/2021 |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Private Equity Investor | 01/12/2007 |
Orbimed Private Investments VII LP
 Orbimed Private Investments VII LP Investment ManagersFinance Orbimed Private Investments VII seeks investment opportunities in private and public healthcare companies located in globally primarily North America, Asia, Europe and Israel. The fund targets companies operating in the fields of biopharmaceutical, medical device, diagnostics and healthcare services. It provides financing for seed stage capital for large publicly traded companies. | Corporate Officer/Principal | - |
Anciens postes connus de David Bonita
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de David Bonita
| Harvard University | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 9 |
|---|---|
| MORGAN STANLEY | Finance |
| TRICIDA, INC. | Health Technology |
| SI-BONE, INC. | Health Technology |
| VIEWRAY, INC. | Health Technology |
| ACUTUS MEDICAL, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| REPARE THERAPEUTICS INC. | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| THIRD HARMONIC BIO, INC. | Health Technology |
| Entreprise privées | 16 |
|---|---|
UBS Securities LLC
 UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Finance |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Finance |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Technology |
Keystone Heart Ltd.
 Keystone Heart Ltd. Medical SpecialtiesHealth Technology Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel. | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Edwards Lifesciences CardiaQ LLC
 Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Edwards Lifesciences CardiaQ LLC operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement. The firm focuses on mitral regurgitation which is the most commonly occurring heart valve disease. The company was founded by Arshad Quadri and J. B. Ratz in 2007 and is headquartered in Irvine, CA. | Health Technology |
Viewray Technologies, Inc.
 Viewray Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Viewray Technologies, Inc. develops radiation therapy technology for the treatment of cancer. It operates through the MRIdian system software. The company was founded by James F. Dempsey and Russell S. Donda in March 2004 and is headquartered in Oakwood Village, OH. | Commercial Services |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada. | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Cryterion Medical, Inc.
 Cryterion Medical, Inc. Medical/Nursing ServicesHealth Services Cryterion Medical, Inc. operates a medical laboratory that utilizes cryoablation platform. The company was founded on October 11, 2016 and is headquartered in Carlsbad, CA. | Health Services |
Imaxio SA
 Imaxio SA Medical SpecialtiesHealth Technology Imaxio SA develops biopharmaceutical products. It operates as a biotech company which focuses on vaccines, and based on the combination of commercial and research and development activities. The firm provides its services based on proprietary and Agilent DNA chips, notably CGH micro-array analyses. The company was founded by Christian Pradeyrol and Jean Chatellier in 2000 and is headquartered in Lyon, France. | Health Technology |
Sublimity Therapeutics Ltd.
 Sublimity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sublimity Therapeutics Ltd. develops and manufactures pharmaceutical products. It engages in the development of gastrointestinal and immunological therapeutics. The firm’s lead product, CyCol, harnesses the powerful efficacy of the known immunosuppressive drug, cyclosporine in a safer format by targeting drug release towards the site of diseased tissue in the colon of patients with ulcerative colitis. Its other products include CyCron, AlloCol, CyLow, oral vaccines and oral peptides. The company was founded by Ivan Coulter in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Health Technology |
| Auraeda, Inc. | |
Orbimed Private Investments VII LP
Orbimed Private Investments VII LP Investment ManagersFinance Orbimed Private Investments VII seeks investment opportunities in private and public healthcare companies located in globally primarily North America, Asia, Europe and Israel. The fund targets companies operating in the fields of biopharmaceutical, medical device, diagnostics and healthcare services. It provides financing for seed stage capital for large publicly traded companies. | Finance |
